Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Blood plasma trial finds no benefit for severely ill patients

Blood plasma trial finds no benefit for severely ill patients

KATE KELLAND AN international trial testing convalescent blood plasma in cases of moderate and severe COVID-19 has halted enrolment of severely ill patients requiring intensive care after finding the plasma was of no benefit, trial investigators have said The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product - an antibody-rich plasma taken from people who have recovered from the pandemic disease - did not improve outcomes. "There was no evidence of harm associated with the administration of convalescent plasma" (and)…
Read More